Andrey Sgibnev

Dr. Andrey Sgibnev

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 October 2015 in Jundishapur Journal of Microbiology
Verified
Journal Article
Open access
PDF file
ASAndrey Sgibnev
Andrey Sgibnev
EKElena A. Kremleva
Elena A. Kremleva
Background: Peroxide-producing lactobacilli provide protection from infection for the female reproductive tract. However, in vitro studies demonstrated that H2O2-produced by Lactobacillus is not the cause of inhibition of pathogens. It is not exactly known how H2O2-producing lactobacilli are involved in the protection of the vaginal environment. Objectives: This study aimed to evaluate the importance of the interaction between H2O2-producing lactobacilli and their host for the resistance of the vaginal biotope. Materials and Methods: In this study, we used vaginal lactobacilli (11 H2O2-roducing strains and 11 non-H2O2-producing strains). The influence of epithelial cells on the growth and antibacterial activity of lactobacilli were evaluated. The effects of lactobacilli on the antibacterial activity of the epithelial cells, muramidase and lactoferrin were also determined. Results: Vaginal epithelial cells stimulated the growth and antibacterial activity of H2O2-producing lactobacilli in a greater extent than that of the non-H2O2-producing lactobacilli. Mainly, the H2O2-producing lactobacilli were capable of increasing the activity of the host antimicrobial peptides (muramidase and lactoferrin) as well as the antibacterial activity of the epithelial cells. Conclusions: The involvement of the peroxide-producing lactobacilli in the protection of vagina was due to their ability to effectively interact with the host. This is expressed on one side to stimulate the growth and antagonistic activity of lactobacilli and on the other side to increase the antibacterial activity of the host defense factors (muramidase, lactoferrin and metabolites of epithelial cells). Keywords: Epithelial Cells; Host-Pathogen Interactions; Hydrogen Peroxide; Immunity; Innate; Lactoferrin; Muramidase; Vagina; Lactobacillus


8 November 2019 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Closed access
PDF file
ASAndrey Sgibnev
Andrey Sgibnev
EKElena Kremleva
Elena Kremleva

18 May 2023 in Polymers
Verified
Journal Article
Open access
PDF file
Natallia DubashynskayaNatallia Dubashynskaya
Natallia Dubashynskaya
VPValentina A. Petrova
Valentina A. Petrova
ASAndrey Sgibnev
Andrey Sgibnev
VEVladimir Elokhovskiy
Vladimir Elokhovskiy
YCYuliya I. Cherkasova
Yuliya I. Cherkasova
Yury A. SkorikYury A. Skorik
Yury A. Skorik
The development of polymeric carriers based on partially deacetylated chitin nanowhiskers (CNWs) and anionic sulfated polysaccharides is an attractive strategy for improved vaginal delivery with modified drug release profiles. This study focuses on the development of metronidazole (MET)-containing cryogels based on carrageenan (CRG) and CNWs. The desired cryogels were obtained by electrostatic interactions between the amino groups of CNWs and the sulfate groups of CRG and by the formation of additional hydrogen bonds, as well as by entanglement of carrageenan macrochains. It was shown that the introduction of 5% CNWs significantly increased the strength of the initial hydrogel and ensured the formation of a homogeneous cryogel structure, resulting in sustained MET release within 24 h. At the same time, when the CNW content was increased to 10%, the system collapsed with the formation of discrete cryogels, demonstrating MET release within 12 h. The mechanism of prolonged drug release was mediated by polymer swelling and chain relaxation in the polymer matrix and correlated well with the Korsmeyer–Peppas and Peppas–Sahlin models. In vitro tests showed that the developed cryogels had a prolonged (24 h) antiprotozoal effect against Trichomonas, including MET-resistant strains. Thus, the new cryogels with MET may be promising dosage forms for the treatment of vaginal infections.

23 November 2016 in Bulletin of Experimental Biology and Medicine
Verified
Journal Article
Closed access
PDF file
EKE. A. Kremleva
E. A. Kremleva
ASAndrey Sgibnev
Andrey Sgibnev

1 November 2007 in Bulletin of Experimental Biology and Medicine
Verified
Journal Article
Closed access
PDF file
ASA. V. Semenov
A. V. Semenov
ASAndrey Sgibnev
Andrey Sgibnev
SCS. V. Cherkasov
S. V. Cherkasov
OBO. V. Bukharin
O. V. Bukharin